Page last updated: 2024-10-28

hydroxyurea and Factor XIII Deficiency

hydroxyurea has been researched along with Factor XIII Deficiency in 1 studies

Factor XIII Deficiency: A deficiency of blood coagulation FACTOR XIII or fibrin stabilizing factor (FSF) that prevents blood clot formation and results in a clinical hemorrhagic diathesis.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petri, M1
Ellman, L1
Carey, R1

Other Studies

1 other study available for hydroxyurea and Factor XIII Deficiency

ArticleYear
Acquired factor XIII deficiency with chronic myelomonocytic leukemia.
    Annals of internal medicine, 1983, Volume: 99, Issue:5

    Topics: Aged; Factor XIII Deficiency; Female; Hematoma; Humans; Hydroxyurea; Leukemia, Myeloid; Leukocyte Co

1983